Three health care distribution industry trends to watch
The latest Factbook reveals that approximately 95 percent of all pharmaceutical sales moved through the traditional distribution segment in 2023, among other key findings.
HDA
HDA convenes supply chain experts and patient advocates to examine drug shortages solutions
HDA recently hosted a LinkedIn Live discussion exploring how supply chain stakeholders are working together to tackle these challenges and advocate for solutions.
HDA Factbook: Rx sales through traditional health care distributors remain strong in 2023
Pharmaceutical distributor sales reached $758 billion amid some of the lowest profit margins in the study’s 95-year history — 0.3 percent (net after taxes) and 1.7 percent (gross) in 2023.
HDA issues statement on FDA’s phased exemption for eligible trading partners from the DSCSA’s final implementation requirements
“HDA and our pharmaceutical distributor members applaud the FDA’s decision to grant an exemption for the DSCSA’s enhanced drug distribution security (EDDS) requirements for eligible trading partners."